Article
Contribution of clinical screening to carrier detection in a large Chinese family with Fabry disease due to a novel alpha-galactosidase A gene deletion.
European journal of neurology - 1 May 2007
Ro L-S, Chen C-M, Chang H-S, Lyu R-K, Wu Y-R, Hsu W-C, Lee-Chen G-J
Abstract excerpt
Diagnosis of heterozygous Fabry patients is difficult because of its variable clinical manifestations and overlapping serum alpha-galactosidase A (AGA) activity between carriers and non-carriers. We tried to facilitate diagnosis of heterozygous Fabry patients by detailed clinical examination. We analyzed clinical presentations, biochemical, electrophysiological and genetic characteristics of 16 patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
